Our study shows that the PIV and MLR are significant predictors of PCa and CSPCa diagnoses in patients with PSA levels from 4.0 to 20.0 ng/mL, and they may be useful to avoid unnecessary biopsies or biopsy-related morbidities in real clinical practice. Here, KLK3 is linked to posterior cortical atrophy.